Colloidal gold: a novel nanoparticle for targeted cancer therapeutics.

Anathea C. Powell, Giulio F. Paciotti, Steven K. Libutti

Research output: Contribution to journalReview articlepeer-review

59 Scopus citations


Since their initial description in 1857, gold nanoparticles have been used extensively in the fields of diagnostics and therapeutics. Now, gold nanoparticles are engineered to target the delivery of potent anti-cancer therapeutics to solid tumors to improve either their safety or efficacy or both. Described in this chapter is the development of one such nanotherapeutic, termed CYT-6091, that targets the delivery of tumor necrosis factor alpha (TNF) to solid tumors. Outlined in the presentation is a discussion of nanoparticles and specifically colloidal gold, an historical review on the biology of TNF and its limited use in the clinic when administered systemically, and finally, how gold nanoparticles bound with TNF may improve the safety and efficacy profiles of TNF.

Original languageEnglish (US)
Pages (from-to)375-384
Number of pages10
JournalMethods in molecular biology (Clifton, N.J.)
StatePublished - 2010
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Genetics


Dive into the research topics of 'Colloidal gold: a novel nanoparticle for targeted cancer therapeutics.'. Together they form a unique fingerprint.

Cite this